J. L. Pico
- Hematology top 5%
- Surgery top 10%
- Molecular Biology
- Oncology
- Public Health, Environmental and Occupational Health top 10%
- Topics
- Hematopoietic Stem Cell Transplantation (7 papers)Testicular diseases and treatments (4 papers)Immunotherapy and Immune Responses (4 papers)
- Partner nations
- FranceItalySwitzerland
In The Last Decade
J. L. Pico
23 papers receiving 854 citations
Peers
Comparison fields: 5 of 70
- Hematology 306
- Surgery 282
- Molecular Biology 231
- Oncology 211
- Public Health, Environmental and Occupational Health 174
Countries citing papers authored by J. L. Pico
This map shows the geographic impact of J. L. Pico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Pico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Pico more than expected).
Fields of papers citing papers by J. L. Pico
This network shows the impact of papers produced by J. L. Pico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Pico. The network helps show where J. L. Pico may publish in the future.
Co-authorship network of co-authors of J. L. Pico
This figure shows the co-authorship network connecting the top 25 collaborators of J. L. Pico. A scholar is included among the top collaborators of J. L. Pico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. Pico. J. L. Pico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 1 | |
| 3 | Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission. | 52 |
| 4 | Recent progress in the biology of multiple myeloma and future directions in the treatment. | 3 |
| 5 | 96 | |
| 6 | 28 | |
| 7 | 7 | |
| 8 | 211 | |
| 9 | Fluorescence in situ hybridization with X and Y DNA specific probes for chimerism detection in pulmonary alveolar macrophages after human sex-mismatched allogeneic bone marrow transplantation. | 1 |
| 10 | 14 | |
| 11 | 22 | |
| 12 | A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors. | 26 |
| 13 | 36 | |
| 14 | 10 | |
| 15 | 22 | |
| 16 | Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine. | 47 |
| 17 | 9 | |
| 18 | Modifications of lectin binding on human leukemic cells after neuraminidase treatment. | 1 |
| 19 | 217 | |
| 20 | 41 |
About J. L. Pico
J. L. Pico is a scholar working on Hematology, Immunology and Neurology, having authored 23 papers that have together received 894 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (7 papers), Testicular diseases and treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Hematology (306 citations), Neurology (149 citations) and Reproductive Medicine (73 citations). J. L. Pico has collaborated with scholars based in France, Italy and Switzerland. Frequent co-authors include C. Rosenfeld, A Goutner, A.M. Vénuat, B Kayibanda, M. F. Greaves, J P Droz, A. Kramar, J. Beyer, Craig R. Nichols and Hans‐Joachim Schmoll. Their work appears in journals such as Nature, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.